Zusduri medication
Ended Awarded
- Contract number
- 36C24626N0375
- Awardee
-
Urogen Pharma Inc. UEI L3U3BFJL3Z81
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $32,844
Award facts
- Contract value 100% obligated
- $32,844.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order to Urogen Pharma Inc. for Zusduri medication on December 9, 2025, with a ceiling value of $32,844.22. This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of January 9, 2026. The contract was awarded on a full and open basis with no set-aside designation. Urogen Pharma Inc., a for-profit pharmaceutical company headquartered in Princeton, New Jersey, specializes in providing specialized pharmaceutical treatments to the VA healthcare system, with particular expertise in oncology medications.
Zusduri is a mitomycin-based treatment administered for low-grade upper tract urothelial cancer, a specialized therapeutic area in which Urogen Pharma has established itself as a key supplier to the VA. The delivery order will be performed in Dublin, Ohio. This award reflects the continued strategic relationship between Urogen Pharma and the VA, building on the company's existing indefinite delivery vehicles with the agency, including a $2.5 million blanket purchase agreement valid through February 2026. The award supports the VA's mission to provide specialized cancer treatments to veterans across multiple regional healthcare networks.
Quick answers
Who was awarded contract 36C24626N0375?
36C24626N0375 was awarded to Urogen Pharma Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on December 9, 2025.
How much is contract 36C24626N0375 worth?
The government has obligated $32,844 on 36C24626N0375.
Is contract 36C24626N0375 an order under another contract?
Yes. 36C24626N0375 is a delivery order under 36F79721D0068, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0375 competed?
The extent of competition for 36C24626N0375 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award